News

Zacks Investment Research on MSN2d
Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 Earnings
Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which ...
Zacks Investment Research on MSN10d
How Will Pfizer's Oncology Drugs Perform in Q2 Earnings?
Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of Seagen. The deal added four antibody-drug conjugates (ADC) — Adcetris, Padcev, ...